These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17237429)

  • 21. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.
    Webster KE; Walters S; Kohler RE; Mrkvan T; Boyman O; Surh CD; Grey ST; Sprent J
    J Exp Med; 2009 Apr; 206(4):751-60. PubMed ID: 19332874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta.
    Liu VC; Wong LY; Jang T; Shah AH; Park I; Yang X; Zhang Q; Lonning S; Teicher BA; Lee C
    J Immunol; 2007 Mar; 178(5):2883-92. PubMed ID: 17312132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.
    Lavasani S; Dzhambazov B; Nouri M; Fåk F; Buske S; Molin G; Thorlacius H; Alenfall J; Jeppsson B; Weström B
    PLoS One; 2010 Feb; 5(2):e9009. PubMed ID: 20126401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
    Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
    Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10.
    Stohlman SA; Pei L; Cua DJ; Li Z; Hinton DR
    J Immunol; 1999 Dec; 163(11):6338-44. PubMed ID: 10570329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.
    Every AL; Kramer DR; Mannering SI; Lew AM; Harrison LC
    J Immunol; 2006 Apr; 176(8):4608-15. PubMed ID: 16585551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
    Faunce DE; Terajewicz A; Stein-Streilein J
    J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-γ- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis.
    Zhao J; Zhao J; Fett C; Trandem K; Fleming E; Perlman S
    J Exp Med; 2011 Aug; 208(8):1571-7. PubMed ID: 21746812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.
    Benkhoucha M; Santiago-Raber ML; Schneiter G; Chofflon M; Funakoshi H; Nakamura T; Lalive PH
    Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6424-9. PubMed ID: 20332205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation.
    Esposito M; Ruffini F; Bellone M; Gagliani N; Battaglia M; Martino G; Furlan R
    J Neuroimmunol; 2010 Mar; 220(1-2):52-63. PubMed ID: 20149931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis.
    Zhang H; Podojil JR; Chang J; Luo X; Miller SD
    J Immunol; 2010 Jun; 184(12):6629-36. PubMed ID: 20483764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
    DeOca KB; Moorman CD; Garcia BL; Mannie MD
    Front Immunol; 2020; 11():541619. PubMed ID: 33072087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.